TNF-alpha and TNF-beta — Drug Target

All drugs that target TNF-alpha and TNF-beta — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

TNF inhibitor (TNF receptor fusion protein)

Phase 3 pipeline (1)

• Etanercept / Autoinjector A · Amgen · TNF inhibitor (TNF receptor fusion protein) · Immunology
  Etanercept is a TNF receptor fusion protein that binds and neutralizes tumor necrosis factor (TNF), a key inflammatory cytokine.